Abstract
Pelvic inflammatory disease (PID) has been described in the medical literature for more than a century as a specific entity.Neisseria gonorrhoeae, Chlamydia trachomatis, andMycoplasma hominis, along withBacteroides fragilis and other anaerobic bacteria, have been most frequently associated with PID. Factors affecting the occurrence of PID have been extensively studied during the past two decades and include number of sexual partners, age, race, socioeconomic status, education, and contraceptive method. As knowledge concerning factors that contribute to PID increases, epidemiologic studies addressing such issues must become increasingly sophisticated, and the literature needs to be re-evaluated in light of present knowledge. Various risk factors for PID, types of epidemiologic studies, methods for conducting such studies, and data interpretation are reviewed.
Resumé
Il y a plus d'un siècle que la salpingite aiguë est décrite comme une entité spécifique dans la littérature médicale. Elle est généralement due àNeisseria gonorrhoeae, Chlamydia trachomatis etMycoplasma hominis, ainsi qu'àBacteroides fragilis et à d'autres bactéries anaérobies. Des études approfondies ont été conduites au cours des 2 dernières décennies, à propos des facteurs favorisant les salpingites: il s'agit notamment du nombre de partenaires sexuels, de l'âge, de la race, du niveau socio-économique, de l'éducation et des méthodes contraceptives. Plus notre connaissance des facteurs favorisant les salpingites s'améliore, et plus les études épidémiologiques concernant ces questions doivent être sophistiquées. En outre, il convient de revoir la littérature à la lumière des connaissances actuelles. On décrit divers facteurs de risque de salpingite, les types d'études épidémiologiques, les méthodes adoptées pour conduire ces études et l'interprétation de leurs résultats.
Resumen
La enfermedad inflamatoria pelviana (PID) ha sido descripta en la literatura médica durante mas de un siglo como una entidad separada.Neisseria gonorrhoeae, Chlamydia trachomatis, yMycoplasma hominis, junto conBacteroides fragilis y otras bacterias anaerobias, han sido mas frecuentemente asociadas con la inflamación pelviana. Durante las 2 últimas decadas se han estudiado extensamente los factores que afectan la ocurrencia de la inflamación pelviana e incluyen el número de contactos sexuales, edad, raza, nivel socioeconómico, educación y métodos contraceptivos. Como el conocimiento concerniente a factores que contribuyen a la inflamación pelviana está en aumento, los estudios epidemiológicos referentes a tales, deben volverse progresivamente más sofisticados y la literature necesita ser reevaluada a la luz de los conocimientos actuales. Se consideran varios factores de riesgo para la inflamación pelviana, tipos de estudios epidemiológicos, méthodos para conducir tales estudios e interpretación de datos.
Similar content being viewed by others
References
RubinA. (1955). Microwave therapy of chronic pelvic inflammatory disease.Obstet. Gynecol.,5, 157–159
KellyH. (1898).Operative Gynecology, Vol. II, Appleton, New York, pp. 199, 212, 374, 412, 432–433
BrunetW. M. and SalbergJ. B. (1938). Fregnancy complicated by gonococcic salpingitis,Am. J. Obstet. Gynecol.,35, 1056–1057
KriogE. G. (1941). Clinical experience in the treatment of pelvic inflammatory disease with intradermal injections ofBacillus coli vaccine.Am. J. Obstet. Gynecol.,41, 105
KriegE. G. (1942). The treatment of pelvic inflammatory disease with intradermal administration ofBacillus coli vaccine.Am. J. Obstet. Gynecol.,44, 631
MårdhP. A., LindL., SvenssonL., WeströmL. and MellerB. R. (1981). Antibodies toChlamydia trachomatis, Mycopiasma hominis, andNeisseria gonorrhosae in sera from patients with acute salpingitis.Br. J. Vener. Dis.,57, 125–129
SchachterJ. (1982). Sexually transmittedChlamydia trachomatis infection.Postgrad. Med.,72, 60–69
SchachterJ., StenerE. and MoncadaJ. (1983). Screening for chlamydial infestions in women attending family planning clinics: evaluation of presumptive indicators for therapy.West. J. Med.,138, 375–379
SweetR., SchachterJ. and RobbieM. (1982). Acute salpingitis; role of Chlamydia in the United States. In.Chlamydial Infections, Elsevier, New York, pp. 175–178
MøllerB. R. (1983). The role of Mycoplasma in the upper genital tracts of women.Sex. Transmiss. Dis.,10S, 28–288
MøllerB. R., MardhP., AhrensS. and NusslerE. (1981). Infection withChlamydia trachomatis, Mycoplasma hominis andNeisseria gonorrhoeae in patients with acute pelvic inflammatory disease.Sex. Transmiss. Dis.,8, 198–202
PaavonenJ., MiettinenA., StevensC. E., ChenK. C. S. and HolmesK. K. (1983).Mycoplasma hominis in nonspecific vaginitis,Sex. Transmiss. Dis.,10S, 271
CarterR., JonesC. P., AlterR. L., CreadickR. N. and ThomasW. L. (1953).Bacteroides infections in obstetrics and gynecology.Obstet. Gynecal.,3, 491
PaavonenJ., ValtonenV. V., KasperD. L., MalkamakiM. and MakelaP. H. (1981). Seriological evidence for the role ofBacteroides fragilis and enterobacteriaceae in the pathogenesis of acute pelvic inflammatory disease.Lancet,2, 293–295
SweetR. L. (1981). Treatment of mixed aerobic-anaerobic infections of the female genital tract.J. Antimicrobial Chemother.,8, 105–114
PritschH. O., HofstatterA. and LindnerK. (1910). Experimentelle Studien zur Trachomfrage,v.Graefe's Arch. Ophthalmol.,76, 547
HalberstaedterL. and VonProwazekS. (1907). Ueber chlamyozoenbefunde bei Blennorhae neionatorum non gonorrhoica.Arb. Gesund. Amte.,26, 44–47
HareM. J. and ThinR. N. (1983). Chlamydial infection of the lower genital tract of women.Br. Med. Bull.,39, 138–144
HeymannB. (1910). Uber die Fundorte der Prowazek'shen Korperchen.Berliner Klin. Wochenschr,47, 663–666
SchachterJ. and DawsonC. R. (1978). Genital tract infections. In:Human Chlamydial Infections, PSG, Inc., Littleton, MA, pp. 121–139
DienesL. and EdsallG. (1937). Observations on the L-Organism of Klieneberger.Prac. Soc. Exp. Biol. Med.,36, 740–744
FreundtE. A. (1983).Mycoplasma hominis: historical outline and taxonomy.Sex. Transmiss. Dis.,10(4), 226–229S
FreundtE. A. (1958).The Mycoplasmataceae (The Pleuropneumonia Group of Organisms): Morphology, Biology and Taxonomy, Munksgaard, Copenhagen
LemckeR. and CsonkaG. W. (1962). Antibodies against pleuropneumonia-like organisms in patients with salpingitis.Br. J. Vener. Dis.,38, 212–217
MårdhP. A. and WeströmL. (1970). Tubal and cervical cultures in acute salpingitis with special reference toMycoplasma hominis and T-strain mycoplasmas.Br. J. Vener. Dis.,46, 179–186
MelenB. and GotthardsonA. (1955). Complement fixation with human pleuropneumonia-like organisms.Acta. Pathol. Microbiol. Scand.,37, 196–200
MeittinenA., PaavonenJ., JanssonE. and LeinikkiP. (1983). Enzyme immunoassay for serum antibody toMycoplasma hominis in women with acute pelvic inflammatory disease.Sex. Transmiss. Dis.,10S, 289–293
StemmerVonW. (1981). Uber die Ursachen von Einleiterentzundungen (On the cause of the introduction of inflammation).Zentralbl. Gynak.,22, 1061
HedbergE. and SpetzS. (1958). Acute salpingitis.Acta Obstet. Gynecol. Scand.,37, 131
KeithL. G., BergerG. S., EdelmanG. A., NewtonW., FullanN., BaileyR. and FribergJ. (1984). On the causation of pelvic inflammatory disease.Am. J. Obstet. Gynecol.,149, 215–224
BurkmanR. T. (1980). Intrauterine device use and the risk of pelvic inflammatory disease.Am. J. Obstet. Gynecol.,36, 452–454
FleshG., WeinerJ. M., CorlettR. C., BoiceC., MishellD. R. and WolfR. M. (1979). The intrauterine contraceptive device and acute salpingitis.Am. J. Obstet. Gynecol.,135, 402–408
McCormackW. M. (1983). Epidemiology ofMycoplasma hominis.Sex. Transmiss. Dis.,10S, 261–262
StadelB. V. and SchlesselmanS. (1984). Extent of surgery for pelvic inflammatory disease in relation to duration of intrauterine device use.Obstet. Gynecol.,63, 171–178
WeströmL. and MårdhP. A. (1982). Pelvic inflammatory disease: epidemiology, diagnosis, clinical manifestations, and sequelae. In:International Perspectives on Neglected Sexually Transmitted Diseases, K. K.Holmes and P. A.Mårdh, eds., Hemisphere Publishing Co., New York, pp. 235–250
WeströmL. (1983). Clinical manifestations and diagnosis of pelvic inflammatory disease.J. Reprod. Med.,28, 703–708S
BoothM. and BeralV. (1980). Effect of age on pelvic inflammatory disease in nulliparous women using a Copper 7 intrauterine contraceptive device.Br. Med. J.,281, 14–15
Centers for Disease Control, NDTI, NAMCS (1965–1981). Statistical services, Div. Venereal Disease Control. Total Visits for PID and Rates Per 100 000 Population for Age Groups 15–50 and with Women in Age-Groups 15–50. United States Calendar Years 1965–1981. (Unpublished data)
LuukkainenT., NielsenN., NygrenK., PyöräläT. and AllonenH. (1979). Combined and national experience of postmenstrual IUD insertions of Nova-T and Copper-T in a randomized study.Contraception,19, 11–20
O'BrienF. B., StewartW. C. and SturtevantF. M. (1983). Incidence of pelvic inflammatory disease in clinical trials with Cu-7 (intrauterine contraceptive device): a statistical analysis.Contraception,27, 111–122
WeströmL. (1980). Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.Am. J. Obstet. Gynecol.,138, 880–891
Eschenbach, D. A. (1977). Epidemiology and diagnosis of acute pelvic inflammatory disease.Obstet. Gynecol.,55, 142S
WeströmL., BengtssonL. P. and MårdhP. (1976). The risk of pelvic inflammatory disease in women using intrauterine contraceptive devices as compared to non-users.Lancet,2, 221–224
WrightN. H. and Combined Bangkok Hospital Group. (1975). Unsuspected pelvic infection discovered at tubal location: relationship to use of intrauterine contraception. In:Analysis of Intrauterine Conception, F.Hefnawi and S. J.Segal, eds., North Holland, Amsterdam, pp. 401–409
GumpD. W., GibsonM. and AshikagaT. (1983). Evidence of prior pelvic inflammatory disease and its relationship toChlamydia trachomatis antibody and IUD use in infertile women.Am. J. Obstet. Gynecol.,146, 153–159
KaufmanD. W., WatsonJ., RosenbergS. P., MillerD. R., MeittinenO. S., StolleyP. D. and ShapiroS. (1983). The effect of different types of intrauterine devices on the risk of pelvic inflammatory disease.J. Am. Med. Assoc.,250, 759–762
SparksR. A., PurrierB. G., WattP. J. and ElsteinM. (1981). Bacteriological colonization of uterine cavity: role of tailed intrauterine contraceptive device.Br. Med. J.,282, 1189–1191
WrightN. H. and LaemmleP. (1968). Acute pelvic inflammatory disease in an indigent population.Am. J. Obstet. Gynecol.,101, 979–998
LeeN. C., RubinC. L., OryH. W. and BurkmanR. T. (1983). Type of intrauterine device and the risk of pelvic inflammatory disease.Obstet. Gynecol.,62, 1–6
VesseyM. P., YeatesD., FlavelR. and McPhersonK. (1981). Pelvic inflammatory disease and the intrauterine device: findings in a large cohort study.Br. Med. J.,1, 855–857
SnowdenR. and PearsonB. (1984). Pelvic infection-a comparison of the Dalkon Shield and three other intrauterine devices.Br. Med. J.,288, 1570
MacmahonB. and PughT. F. (1970).Epidemiology: Principles and Methods, Little, Brown & Co., Boston
HorwitzR. I. and FeinsteinA. R. (1979). Methodologic standards and contradictory results in case-control research.Am. J. Med.,66, 556–564
BreslowN. E. and DayN. E. (1980).Statistical Methods in Cancer Research. Vol. 1:The Analysis of Case-Control Studies, IARC, Lyon
WeströmL. (1980). International forum.Int. J. Gynaecol. Obstet.,17, 509–511
TothA. (1983). Alternative causes of pelvic inflammatory disease.J. Repord. Med.,28, 699–702S
TothA., O'LearyW. M. and LedgerW. (1982). Evidence for microbial transfer by spermatozoa.Obstet. Gynecol.,59, 556–558
WitkinS. S. and TothA. (1983). Relationship between genital tract infections, sperm antibodies in seminal fluid, and infertility.Fertil. Steril.,40, 805–808
FribergJ. (1983). Sperm can be vector of germs that cause PID.Obstet. Gynecol. News,18, 3
Wølner-HanssenP. and MårdhP. A. (1984).In vitro tests of the adherence ofChlamydia trachomatis to human spermatozoa.Fertil. Steril.,42, 102
Hafez, E. S. E. (1984). Microbiological contaminants of human semen used forin vitro fertilization: a possible etiology for idiopathic male infertility. Presented at 1st World. Conf. on Infectious Diseases & Human Fertility, 16th March, Lenox Hill Hospital, New York, NY
FowlkesD. M., DooherG. B. and O'LearyW. M. (1975). Evidence by scanning electron microscopy for an association between spermatozoa and T-mycoplasmas in men of infertile marriage.Fertil. Steril.,26, 1203–1211
James-HolmquistA. N., SwansonJ., BuchananT. M., WendeR. D. and WilliamsR. P. (1974). Differential attachment by piliated and nonpiliated gonorrhoeae to human sperm.Infect. Immun.,9, 897–902
KelaghanJ., RubinG. L., OryH. W. and LaydeP. M. (1982). Barrier-method contraceptives and pelvic inflammatory disease.J. Am. Med. Assoc.,248, 184–187
RubinG. L., OryH. W. and LaydeP. M. (1982). Oral contraceptives and pelvic inflammatory disease.Am. J. Obstet. Gynecol.,144, 630–635
ElsteinM. (1978). Functions and physical properties of mucus in the fernale genital tract.Br. Med. Bull.,34, 83–88
TsibrisJ. C., ThomasonJ. L., KunigkA., Khan-DawoodF. S., KirschnerC. V. and SpellacyW. N. (1982). Guaiacol peroxidase levels in human cervical mucus: a possible predictor of ovulation.Contraception,25, 59–67
TargumS. D. and WrightN. H. (1974). Association of the intrauterine device and pelvic inflammatory disease: a retrospective pilot study.Am. J. Epidemiol.,100, 262–271
MishellD. R., BellJ. H., GoodR. G., and MoyerD. L. (1966). The intrauterine device: a bacteriologic study of the endometrial cavity.Am. J. Obstet. Gynecol.,96, 119–126
MishellD. R. (1984). Putting a stop to salpingitis.Emer. Med.,16, 22
LippesJ. (1975). Infection and the IUD-a preliminary report.Contraception,12, 103–106
RydenG., FahraeusL. and AhmanK. (1979). Do contraceptives influence the incidence of acute pelvic inflammatory disease in women with gonorrhea?Contraception,20, 149–157
ThalerJ., PaldiE. and SteinerD. (1978). Intrauterine device and pelvic inflammatory disease.Int. J. Fertil.,23, 69–72
GrahamS. and SimcockB. W. (1982). A review of the use of intrauterine devices in nulliparous women.Contraception,26, 323–346
NygrenK. G., NielsenN. C., PyöräläT., AllonenH. and LuukkainenT. (1983). Nova-T: long-term effectiveness and clinical performance.Acta Obstet. Gynecol. Scand., Suppl.,116, 93
OsserS., LiedholmP., GullbergB. and SjöbergN. O. (1980). Risk of pelvic inflammatory disease among intrauterine device users irrespective of previous pregnancy.Lancet,1, 386–388
WHO Task Force on Intrauterine Devices (1984). PID associated with fertility regulating agents.Contraception,30, 1–21
CunananR. G., CoureyN. G. and LippesJ. (1983). Laparoscopic findings in patients with pelvic pain.Am. J. Obstet. Gynecol.,146, 589–591
ChatmanD. L. (1976). Endometriosis in the black woman.Am. J. Obstet. Gynecol.,125, 987–989
SchachterJ. (1983). Chlamydia usually inapparent; presumptive indicators don't apply.Obstet. Gynecol. News,18(24), 45
SvenssonL., WeströmL. and MårdhP. A. (1984). Contraceptives and acute salpingitis.J. Am. Med. Assoc.,251, 2553
RosenfeldD. L., SeidmanS. M., BronsonS. M. and SchollG. M. (1983). Unsuspected chronic pelvic inflammatory disease in the infertile female.Fertil. Steril.,39, 44–48
GibsonM., GumpD., AshikagaT. and HallB. (1984). Patterns of adnexal inflammatory damage: chlamydia, the intrauterine device, and history of pelvic inflammatory disease.Fertil. Steril.,41, 47
EdwardsL. E., RastogiS. P., HurleyS. K. and HakansonE. Y. (1981). Intrauterine-device-related hospitalizations.Adv. Planned Parenthood,16, 65–70
TatumH. J., SchmidtF. H., PhillipsD., McCartyM. and O'LearyW. M. (1975). Dalkon Shield controversy-structural and bacteriological studies of IUD tails.J. Am. Med. Assoc.,231, 711–717.
PurrierB. G., SparksR. A., WattP. J. and ElsteinM. (1979).In vitro study of the possible role of the intrauterine tract.Br. J. Obstet. Gynaecol.,86, 374–378
SkangalisM., MahoneyC. J. and O'LearyW. M. (1982). Microbial presence in the intrauterine cavity as affected by varieties of intrauterine contraceptive devices.Fertil. Steril.,37, 263–269
Cole, L. P. (1984). IUDs With or Without Strings. Presented at the PARFR Workshop on Intrauterine Contraception: Advances and Future Prospects. Chicago, IL, May 29–June 1
SpornitzU. M., MakabeS., HafezE. S. E. and vanOsW. A. A. (1984). IUD technology — scanning microscopy of the IUD tail.Contracept. Deliv. Syst.,5, 29–45
Ory, H., Forrest, J. D. and Lincoln, R. (1983).Making Choices. Evaluating the Health Risks and Benefits of Birth Control Methods. The Guttmacher Institute, pp. 48–49
WashingtonA. E., CatesW. and ZaidiO. A. (1984). Hospitalization for pelvic inflammatory disease.J. Am. Med. Assoc.,251, 2529
Centers for Disease Control (1984). Gonorrhea-United States, 1983.Morbid. Mortal. Weekly Rep.,33, 361–363
Weisner, P. J. (1980). Magnitude of the problem of sexually transmitted diseases in the United States. In:Sexually Transmitted Disease, 1980 Status Report. NIAID Study Group, NIH Publ. No. 81-2213, pp. 21–31
CatesW. (1984). Sexually transmitted diseases: the national view.Cutis,33, 69–80
AralS. O. and HolmesK. K. (1984). Epidemiology of sexually transmitted diseases. In:Sexually Transmitted Disease, K. K.Holmes, P. A.Mårdh, P. F.Sparling and P. J.Weisner, eds., McGraw-Hill, New York, pp. 126–141
AdlerM. W. (1983). ABC of sexually transmitted diseases: a changing and growing social problem.Br. Med. J.,287, 1279–1283
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Struthers, B.J. Pelvic inflammatory disease, intrauterine contraception, and the conduct of epidemiologic studies. Adv Contracept 1, 63–76 (1985). https://doi.org/10.1007/BF01849145
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01849145